Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Not Confirmed
Not Confirmed
04-06 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Industry Trade Show
Not Confirmed
04-06 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Digital content

18 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kechow-pharma-announces-nmpa-approval-of-tunlametinib-hl-085-as-the-first-targeted-therapy-for-patients-with-nras-mutated-advanced-melanoma-and-previously-treated-with-pd-1pd-l1-302091342.html
ABOUT THIS PAGE